Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown3100%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

New Biomarkers in Facioscapulohumeral Muscular Dystrophy, Multispectral Optoacoustic Tomography.

NCT05902884
unknownnot_applicable

MSOT Using Cetuximab-800CW for Detection of Cervical Lymph Node Metastases

NCT03923881
unknownnot_applicable

In Vivo Multispectral Optoacoustic Imaging of Thyroid Nodules

NCT04730726

Clinical Trials (3)

Showing 3 of 3 trials
NCT05902884Not Applicable

New Biomarkers in Facioscapulohumeral Muscular Dystrophy, Multispectral Optoacoustic Tomography.

Unknown
NCT03923881Not Applicable

MSOT Using Cetuximab-800CW for Detection of Cervical Lymph Node Metastases

Unknown
NCT04730726Not Applicable

In Vivo Multispectral Optoacoustic Imaging of Thyroid Nodules

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3